CD8A and hepatocellular carcinoma: DDP could inhibit tumor growth and decrease tumor volume in DEN/TCPOBOP-induced HCC mice, increase the number of CD8+ T cells in the tumor, reduce the proportion of PD-1+CD8+ T cells in the peripheral blood and spleen of mice, and reduce the immune exhaustion of the tumor microenvironment in HCC.